All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2011-001023-21 | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of DRL-17822 in Patients with Type II Hyperlipidemia Studio randomizzato, in doppi... | 2012-04-10 | due-trials |
| Completed, but no date, and reported results | 2012-002302-43 | A study to investigate the analgesic effects of buprenorphine and milnacipram in healthy volunteers. | bad-data | |
| Reported results | 2015-004765-90 | A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks | 2016-11-21 | due-trials |
| Completed, but no date | 2015-005486-23 | A Multi-center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of DFD-04 (itraconazole) Ointment, 5% in Patients with Inflammatory L... | bad-data | |
| Completed, but no date, and reported results Terminated | 2016-003197-41 | A Multi-Center, Randomized, Double-Blind, Parallel-Group, Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules for the Treatment of Inflammatory Le... | bad-data | |
| Completed, but no date, and reported results | 2017-000262-30 | Efficacy, Safety, Tolerability and Pharmacokinetics of EXN-32 and EXN-44 in patients with Parkinson¿s Disease experiencing motor fluctuations Efficacy, Safety, Tolerability and Pharmacokinetics of ... | bad-data | |
| Listed as ongoing, but also has a completion date | 2018-004223-36 | A Randomised, Double-blind, Parallel-group, Phase III Study to Compare the Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) with MabThera® in Subjects with Previously Unt... | 2023-02-27 | bad-data |
| Reported results | 2019-002810-37 | A Randomized, Double-Blind, Parallel Group, Multicenter Study to Assess the Immunogenicity and Safety of Transitioning Subjects With Rheumatoid Arthritis to Biosimilar Rituximab (DRL_RI) or Continued ... | 2022-04-20 | due-trials |
| Not reported | 2021-005382-40 | A Multicenter, Randomized, Double-Blind, Parallel-Group, Active and Placebo-Controlled Study to Assess the Safety, Efficacy, and Tolerability of Oral DFD-29 Extended Release Capsules for the Treatment... | 2023-05-15 | due-trials |